Published in AIDS Weekly, November 12th, 2001
"We have analyzed the influence of codon usage modifications on the expression levels and immunogenicity of DNA vaccines encoding the human immunodeficiency virus type 1 (HIV-1) group-specific antigen (Gag)," explained Ralf Wagner and colleagues at the University of Regensburg's Institute of Molecular Microbiology and the University of Ulm Institute of Medical Microbiology and Immunology.
Improving the efficiency of the gene sequences coding for Gag enhanced the immunogenicity of these vaccines, Wagner...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.